Cambridge University Hospitals NHS Foundation Trust, in partnership with the University of Cambridge, has been designated as one of the government's new Comprehensive Biomedical Research Centres, and will receive substantial new Research and Development funding from the National Institute for Health Research (NIHR).
Cambridge University Hospitals NHS Foundation Trust, in partnership with the University of Cambridge, has been designated as one of the government's new Comprehensive Biomedical Research Centres, and will receive substantial new Research and Development funding from the National Institute for Health Research (NIHR).
Cambridge University Hospitals (Addenbrooke's and the Rosie) with the University's School of Clinical Medicine are one of the very few places in the UK that provides a centre of research excellence together with a complete clinical infrastructure.
The site, with the associated presence of the Medical Research Council, and now Cancer Research UK, is already a leading centre for biomedical research, and this award will enable us to develop our potential even further.
In the hospital, clinical teams work alongside world-class scientists and it is this co-existence of experience and expertise that fosters translational research - turning basic science into new drugs and new therapies to improve patient care.
In making the award the international panel of experts confirmed that the partnership between the Trust and the University is internationally excellent in translational research.
The Biomedical Research Centre will address major health priorities in cancer, cardiovascular disease, obesity diabetes and metabolic disorders, imaging, infection and immunity, genetics, musculoskeletal disorders, neurosciences, transplantation, women's health, and capacity development and training.
Professor Patrick Sissons, Regius Professor of Physic, said: "The need for the NHS and the University to work together has never been greater and our joint strengths will drive forward innovation in the prevention, diagnosis and treatment of ill health. This additional funding will help translate our excellent research into the clinic, and will provide an environment which will enable us to make the campus an academic health centre of international standing."
Dr Mary Archer, Chairman of the Trust, said: "We are delighted with the news. It is another significant milestone in our 2020 Vision, the joint plan devised by the Trust, the University and the MRC to develop our site into the Cambridge Biomedical Campus, a world-class centre for research and healthcare."
This work is licensed under a Creative Commons Licence. If you use this content on your site please link back to this page.
